Novozymes Other Operating Income or Expenses 2011-2023 | NVZMY
Novozymes other operating income or expenses for the twelve months ending December 31, 2023 were $-0.059B, a 299.66% decline year-over-year.
- Novozymes annual other operating income or expenses for 2023 were $-0.059B, a 299.66% decline from 2022.
- Novozymes annual other operating income or expenses for 2022 were $0.029B, a 1.53% decline from 2021.
- Novozymes annual other operating income or expenses for 2021 were $0.03B, a 248.65% increase from 2020.